Cymbalta is a drug used to treat depression, anxiety, chronic pain, neuropathy and fibromyalgia. While Cymbalta can make a patient feel better, it is very likely they will face even more life altering pain due to the withdrawal effects, if the patient decides they are ready to stop taking the drug. Eli Lilly, the manufacturer of Cymbalta, is facing litigation from drug users for failing to properly inform of the powerful and dangerous withdrawal effects.
What Symptoms To Look For
Users can experience severe withdrawal symptoms and brain zaps when stopping their dosage of Cymbalta. Brain zaps are shock-like sensations in the brain accompanied by nausea and headaches that inhibit the user’s ability to perform simple tasks. The withdrawal effects can also include dizziness and tunnel vision. These withdrawal symptoms are so strong that some people become dependent on the drug, choosing to continue taking it only to avoid the debilitating effects of stopping their daily dosage.
Claims Against the Manufacturer
Eli Lilly is under scrutiny because Cymbalta''s label and packaging are misleading and provide very little information on the difficulty to discontinue taking the drug. The label deceptively suggests that more than 1 percent of those taking the drug will experience withdrawal, however Eli Lilly found in their own clinical trials that withdrawal would occur in 44 to 50 percent of users.
Claims against Eli Lilly suggest that the manufacturer has not done enough to warn users of the painful withdrawal process – costing patients lost wages, medical bills and a sharp decrease in quality of life.
Lawsuits are proceeding individually in several states now. If you had a life-altering experience with Cymbalta and would like to discuss your situation and possible legal recourse, contact one of the personal injury attorneys at Roberts & Roberts to get answers.